Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1992 | 12-1991 | 09-1991 | 06-1991 | 03-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 950 | 1,038 | 1,435 | 2,255 | 939 |
| Receivables | 292 | 444 | 229 | 80 | 0 |
| Other current assets | 51 | 122 | 2 | 3 | 8 |
| TOTAL | $1,294 | $1,604 | $1,666 | $2,338 | $947 |
| Non-Current Assets | |||||
| PPE Net | 370 | 323 | 319 | 289 | 289 |
| Other Non-Current Assets | 24 | 25 | 24 | 4 | 4 |
| TOTAL | $395 | $349 | $343 | $293 | $293 |
| Total Assets | $1,407 | $1,676 | $1,739 | $2,367 | $981 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 281 | 264 | 146 | 157 | 249 |
| Accrued Expenses | 593 | 621 | 250 | 250 | 242 |
| Other current liabilities | 0 | 0 | 5 | 8 | 7 |
| TOTAL | $874 | $885 | $401 | $415 | $498 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5 | 5 | 16 | 232 | 231 |
| TOTAL | $5 | $5 | $16 | $232 | $231 |
| Total Liabilities | $879 | $890 | $417 | $647 | $729 |
| Shareholders' Equity | |||||
| Common Shares | 329 | 328 | 163 | 162 | 161 |
| Retained earnings | -39,411 | -39,094 | -38,132 | -37,599 | -38,946 |
| Other shareholders' equity | -5 | -6 | -5 | -31 | -31 |
| TOTAL | $528 | $786 | $1,322 | $1,720 | $252 |
| Total Liabilities And Equity | $1,407 | $1,676 | $1,739 | $2,367 | $981 |